Expression of DNA-PKcs and BRCA1 as prognostic indicators in nasopharyngeal carcinoma following intensity-modulated radiation therapy

Yang,Jiao; Xu,Ximing; Hao,Yanrong; Chen,Jiaxin; Lu,Heming; Qin,Jian; Peng,Luxing; Chen,Biao

doi:10.3892/ol.2013.1196

Expression of DNA-PKcs and BRCA1 as prognostic indicators in nasopharyngeal carcinoma following intensity-modulated radiation therapy

Authors:
- Jiao Yang
- Ximing Xu
- Yanrong Hao
- Jiaxin Chen
- Heming Lu
- Jian Qin
- Luxing Peng
- Biao Chen
View Affiliations

Affiliations: Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, P.R. China, Department of Radiotherapy, Clinical Cancer Center, People's Hospital of Guangxi Autonomous Region, Nanning 530021, P.R. China
Published online on: February 18, 2013 https://doi.org/10.3892/ol.2013.1196
Pages: 1199-1204

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The mechanisms of radiation-induced effects in cancer mainly involve double-strand breaks (DSBs) which are important in maintaining the stability of genes. The DNA repair genes breast cancer 1 (BRCA1) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) are capable of maintaining genetic stability through two distinct and complementary repair mechanisms for DNA DSBs, known as repair‑homologous recombination (HR) and non-homologous end joining (NHEJ). DNA-PKcs is a member of the phosphatidylinositol 3-kinase (PI3K) family. The PI3K/AKT cell signaling pathway is implicated in cell migration and invasion. The BRCA1 protein is implicated in multiple complex cellular processes that are related to chromosome sensitivity to mutagens. To determine the protein expression and clinical implications of DNA-PKcs and BRCA1 in nasopharyngeal carcinoma (NPC) and cancer progression, we evaluated its expression status by immunohistochemistry in 87 patients who received intensity‑modulated radiation therapy (IMRT). In NPC, negative expression of DNA-PKcs was detected in 35 of the 87 (40.2%) cancer types and was significantly associated with poor patient survival (P<0.05). The overexpression of DNA-PKcs and BRCA1 also led to significantly improved distant metastasis-free survival compared with patients who did not overexpress both genes, although the expression level of BRCA1 and distant metastasis-free survival were not closely correlated. In addition, multivariate analysis indicated that DNA-PKcs status is a predictive marker of distant metastasis-free survival. In conclusion, lower expression of DNA-PKcs may be correlated with higher distant metastasis in patients with NPC. DNA-PKcs may be a predictive marker of distant metastasis after IMRT, independent of the classical prognostic marker. BRCA1 may additionally exert a synergistic effect to predict distant metastasis-free survival.

View Figures

View References

1	Lee AW, Poon YF, Foo W, et al: Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 23:261–270. 1992.PubMed/NCBI
2	Collis SJ, DeWeese TL, Jeggo PA and Parker AR: The life and death of DNA-PK. Oncogene. 24:949–961. 2005. View Article : Google Scholar : PubMed/NCBI
3	Shrivastav M, De Haro LP and Nickoloff JA: Regulation of DNA double-strand break repair pathway choice. Cell Res. 18:134–147. 2008. View Article : Google Scholar : PubMed/NCBI
4	Weterings E and Chen DJ: The endless tale of non-homologous end-joining. Cell Res. 18:114–124. 2008. View Article : Google Scholar : PubMed/NCBI
5	Peterson SR, Kurimasa A, Oshimura M, et al: Loss of the catalytic subunit of the DNA-dependent protein kinase in DNA double-strand-break-repair mutant mammalian cells. Proc Natl Acad Sci USA. 92:3171–3174. 1995. View Article : Google Scholar
6	Hsu HL, Yannone SM and Chen DJ: Defining interactions between DNA-PK and ligase IV/XRCC4. DNA Repair (Amst). 1:225–235. 2002. View Article : Google Scholar : PubMed/NCBI
7	Lee JW, Yannone SM, Chen DJ, et al: Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro. Cancer Res. 63:22–24. 2003.PubMed/NCBI
8	Obe G and Durante M: DNA double strand breaks and chromosomal aberrations. Cytogenet Genome Res. 128:8–16. 2010. View Article : Google Scholar : PubMed/NCBI
9	Kurimasa A, Ouyang H, Dong LJ, et al: Catalytic subunit of DNA-dependent protein kinase: Impact on lymphocyte development and tumorigenesis. Proc Natl Acad Sci USA. 96:1403–1408. 1999. View Article : Google Scholar : PubMed/NCBI
10	Hall JM, Lee MK, Newman B, et al: Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 250:1684–1689. 1990. View Article : Google Scholar : PubMed/NCBI
11	Quinn JE, Kennedy RD, Mullan PB, et al: BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis. Cancer Res. 63:6221–6228. 2003.PubMed/NCBI
12	Kennedy RD, Quinn JE, Johnston PG and Harkin DP: BRCA1: mechanisms of inactivaion and implications for management of patients. Lancet. 360:1007–1014. 2002. View Article : Google Scholar : PubMed/NCBI
13	Laan R, Baarends WM, Wassenaar E, et al: Expression and possible functions of DNA lesion bypass proteins in spermatogenesis. Int J Androl. 28:1–15. 2005. View Article : Google Scholar : PubMed/NCBI
14	Harris JL and Khanna KK: BRCA1 A-complex fine tunes repair functions of BRCA1. Aging (Albany NY). 3:461–463. 2011.PubMed/NCBI
15	Greene FL, Page DL, Fleming ID, et al: AJCC Cancer Staging Manual. 6th edition. Springer-Verlag; New York, NY: pp. 35–45. 2005
16	Hall EJ: Intensity-modulated radiation therapy, protons, and the risk of second cancer. Int J Radiat Oncol Biol Phys. 65:1–7. 2006. View Article : Google Scholar
17	Chen JX, Guo Y, Li Y, et al: Predicting Radiation Sensitivity of Nasopharyngeal Carcinoma Using Genetic Fingerprinting. Chinese Journal of Clinical Oncology. 34:1141–1145. 2007.
18	Friesland S, Kanter-Lewensohn L, Tell R, et al: Expression of Ku86 confers favorable outcome of tonsillar carcinoma treated with radiotherapy. Head Neck. 25:313–321. 2003. View Article : Google Scholar : PubMed/NCBI
19	Ohta S, Lai EW, Pang AL, et al: Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int J Cancer. 114:139–143. 2005. View Article : Google Scholar : PubMed/NCBI
20	Lee HS, Yang HK, Kim WH and Choe G: Loss of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in gastric cancers. Cancer Res Treat. 37:98–102. 2005. View Article : Google Scholar : PubMed/NCBI
21	Lee HS, Choe G, Park KU, et al: Altered expression of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) during gastric carcinogenesis and its clinical implications on gastric cancer. Int J Oncol. 31:859–866. 2007.
22	Someya M, Sakata K, Monobe M, et al: The association of DNA-dependent protein kinase activity with chromosomal instability and risk of cancer. Carcinogenesis. 27:117–122. 2006. View Article : Google Scholar : PubMed/NCBI
23	Someya M, Sakata KI, Matsumoto Y, et al: The association of DNA-dependent protein kinase activity of peripheral blood lymphocytes with prognosis of cancer. Br J Cancer. 104:1724–1729. 2011. View Article : Google Scholar : PubMed/NCBI
24	Azad A, Jackson S, Cullinane C, et al: Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cells. Mol Cancer Res. 9:1696–1707. 2011. View Article : Google Scholar : PubMed/NCBI
25	Zhuang W, Li B, Long L, et al: Knockdown of the DNA-dependent protein kinase catalytic subunit radiosensitizes glioma-initiating cells by inducing autophagy. Brain Res. 1371:7–15. 2011. View Article : Google Scholar
26	Taghian A, Ramsay J, Allaunis-Turner J, et al: Intrinsic radiation sensitivity may not be the determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 25:243–249. 1993. View Article : Google Scholar : PubMed/NCBI